Results 261 to 270 of about 131,929 (338)

A risk stratification model for coronary artery lesions in Kawasaki disease: focus on subgroup-specific utility. [PDF]

Front Cardiovasc Med
Gong C, Su Z, Li Q, Li H, Wang Z, Gao H, Li Y, Liu X, Deng L.   +8 more
europepmc   +1 more source

Imperative for long-term management and surveillance in Kawasaki disease.

World J Clin Cases
Pan Y, Jiao FY.
europepmc   +1 more source

Lysine lactylation analysis of proteins in the heart of the Kawasaki disease mouse model. [PDF]

Front Cell Dev Biol
Zhuo W, Zhang M, Tan J, Gao Y, Wang Y, Wang N, Ma J, Zhang J, Liu Z, Lv H, Liu Y.   +10 more
europepmc   +1 more source

Issue Information

Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
wiley   +1 more source

Impact of COVID-19 infection on Kawasaki disease and immune status in children. [PDF]

Sci Rep
Gao L, Xu Z, Hu J, Zhang Q, Fu S, Wang W, Xie C, Zhang Y, Wang Y, Gong F.   +9 more
europepmc   +1 more source

ASSESSMENT OF DRUG THERAPY WITH ASPIRIN, PREDNSOLONE, AND γ-GLOBULIN ALONE AND IN COMBINATION IN THE ACUTE STAGE OF KAWASAKI DISEASE

, 1996
Makoto Shinohara, KATSUHIKO SONE, HIROSHI TABATA, Tomio Kobayashi, Takashi Kosuda, Toshihiro Kobayashi, Yoshinari Inoue, Yasunori Okada   +7 more
openalex   +2 more sources

Intracoronary stent implantation with ultrasound guidance for severe coronary artery stenosis after kawasaki disease

, 1998
Masanobu Ishii, Takehisa Ueno, M. Ieomura, T. Sugimura, T. Tautsumi, Etsuo Mori, T. Akagi, Hisao Ikeda, Takahiro Imaizumi, Hiroshi Kato   +9 more
openalex   +1 more source

Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study. [PDF]

Sci Rep
Sajiki D, Nishio N, Kato T, Hirao T, Suzuki K, Go K, Kinoshita F, Kidokoro H, Kawada JI, Sato Y, Takahashi Y.   +10 more
europepmc   +1 more source

Circulating Inflammatory Factors and Bidirectional Mendelian Randomization Analysis in Patients with Kawasaki Disease. [PDF]

Vasc Health Risk Manag
Niu M, Pan J, Wang K, Zhang L, Lin Z, Zhang F.   +5 more
europepmc   +1 more source

IVIG Resistance in Kawasaki Disease: Clinical and Laboratory Risk Factors and the Potential Role of Administration Timing. [PDF]

J Inflamm Res
Peng Y, Jing F, Liu D, Li B, Xu Y, Tan Z, Chen O, Yang Y, Si F, Jiang W, Li C, Cheng Z, Zhou X, Feng S, Su Y, Yi Q.   +15 more
europepmc   +1 more source